logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10420864 B1

PDFFull Text
Date of Patent:
Sep. 24, 2019

Filed:

May. 01, 2017

Hemostatic devices and methods of use

Applicant:

Tyrx, Inc., Monmouth Junction, NJ (US);

Inventors:

Satish Pulapura, Bridgewater, NJ (US);

Fatima Buevich, Highland Park, NJ (US);

Jorie S. Soskin, Edina, MN (US);

Franklin R. Mansfield, Jacksonville, FL (US);

Kai R. Worrell, Hopkins, MN (US);

Charlie Wood, Delano, MN (US);

Assignee:

MEDTRONIC, INC., Minneapolis, MN (US);

Attorney:

Sorell, Lenna & Schmidt, LLP

Primary Examiner:

Susan T Tran

Assistant Examiner:

William Craigo

Int. Cl.
CPC ...
A61K 31/65 (2006.01); A61L 31/04 (2006.01); A61L 31/06 (2006.01); A61L 31/10 (2006.01); A61L 31/14 (2006.01); A61L 31/16 (2006.01); A61K 31/195 (2006.01); A61K 31/496 (2006.01); A61K 31/722 (2006.01);
U.S. Cl.
CPC ...
A61L 31/16 (2013.01); A61K 31/195 (2013.01); A61K 31/496 (2013.01); A61K 31/65 (2013.01); A61K 31/722 (2013.01); A61L 31/04 (2013.01); A61L 31/06 (2013.01); A61L 31/10 (2013.01); A61L 31/146 (2013.01); A61L 31/148 (2013.01); A61L 2300/204 (2013.01); A61L 2300/21 (2013.01); A61L 2300/418 (2013.01);
Abstract

An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a first component having a first substrate and a second component having a second substrate. The second component is positioned within the first component. One of the first and second substrates includes a hemostatic agent and the other of the first and second substrates includes an active pharmaceutical ingredient. Kits, systems and methods are disclosed.

Find Patent Forward Citations

Loading…